tiprankstipranks
Trending News
More News >
Advertisement

AMID - ETF AI Analysis

Compare

Top Page

AMID

Argent Mid Cap ETF (AMID)

Rating:73Outperform
Price Target:
AMID, the Argent Mid Cap ETF, earns a solid overall rating largely because many of its biggest positions—like Victory Capital (VCTR), Comfort Systems USA (FIX), Medpace (MEDP), OneMain (OMF), and Fabrinet (FN)—show strong financial performance, positive earnings call sentiment, and strategic growth initiatives that support the fund’s quality. Some holdings such as LPL Financial (LPLA), HCA Healthcare (HCA), and TopBuild (BLD) face headwinds from high leverage, expensive valuations, or profitability challenges, which slightly weigh on the fund’s rating. A key risk factor is that several core holdings share concerns around high valuations and leverage, which could increase volatility if market conditions worsen.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Strong Mid-Cap Leaders in Top Holdings
Several of the largest positions, such as Medpace, Houlihan Lokey, Comfort Systems, TopBuild, and Victory Capital, have delivered strong year-to-date performance that supports the fund’s returns.
Broad Sector Diversification
Holdings spread across industrials, financials, technology, health care, consumer cyclical, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
Moderate Expense Ratio
The fund’s expense ratio is not especially low, meaning fees may take a noticeable bite out of long-term returns compared with cheaper ETFs.
High U.S. Concentration
With the vast majority of assets in U.S. companies and only a small slice abroad, the ETF offers limited geographic diversification.
Some Lagging Top Holdings
A few key positions, such as HCA Healthcare and Fortinet, have shown weak year-to-date performance, which can drag on overall fund results if the trend continues.

AMID vs. SPDR S&P 500 ETF (SPY)

AMID Summary

Argent Mid Cap ETF (AMID) invests mainly in medium‑sized U.S. companies, aiming for a balance of growth and stability. It doesn’t track a set index, but instead follows a mid-cap theme across many sectors like industrials, financials, technology, and health care. Well-known holdings include HCA Healthcare and cybersecurity firm Fortinet. Someone might invest in AMID to diversify beyond the biggest blue-chip stocks and tap into companies that are still growing but more established than small caps. A key risk is that mid-cap stocks can be more volatile and can go up and down with the overall stock market.
How much will it cost me?The Argent Mid Cap ETF (AMID) has an expense ratio of 0.52%, meaning you’ll pay $5.20 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, which typically involves more research and trading compared to passively managed funds that track an index.
What would affect this ETF?The Argent Mid Cap ETF (AMID) could benefit from economic growth in the U.S., especially if mid-sized companies in sectors like Industrials, Technology, and Health Care continue to innovate and expand. However, rising interest rates or economic slowdowns might negatively impact sectors like Financials and Consumer Cyclical, which are sensitive to borrowing costs and consumer spending. Regulatory changes or shifts in market sentiment could also influence the performance of its top holdings, such as Medpace Holdings and Fortinet.

AMID Top 10 Holdings

Argent Mid Cap ETF leans heavily into U.S. mid-cap health care and financial names, with Medpace and HCA setting much of the tone. Medpace has been rising and looks like one of the fund’s key engines, while HCA’s more mixed, slightly lagging action keeps a bit of a lid on returns. On the financial side, LPL Financial, Houlihan Lokey, and Victory Capital are generally trending higher, quietly pulling their weight. Comfort Systems and TopBuild add an industrial tilt and have been strong climbers, helping offset weakness from lagging tech name Fortinet.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Medpace Holdings5.10%$5.53M$16.96B75.57%
79
Outperform
HCA Healthcare4.26%$4.62M$115.43B49.94%
70
Neutral
LPL Financial3.37%$3.65M$29.22B1.35%
66
Neutral
Houlihan Lokey3.28%$3.55M$12.59B-0.08%
70
Outperform
Victory Capital Holdings3.19%$3.46M$4.47B6.28%
80
Outperform
Comfort Systems3.17%$3.44M$40.93B174.17%
80
Outperform
Fortinet3.02%$3.28M$60.76B-17.37%
71
Outperform
TopBuild2.95%$3.20M$13.49B41.42%
68
Neutral
Somnigroup International2.74%$2.97M$19.04B44.69%
72
Outperform
Fabrinet2.67%$2.90M$17.86B140.01%
78
Outperform

AMID Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
34.29
Positive
100DMA
34.20
Positive
200DMA
33.61
Positive
Market Momentum
MACD
0.19
Positive
RSI
46.81
Neutral
STOCH
19.91
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AMID, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 34.86, equal to the 50-day MA of 34.29, and equal to the 200-day MA of 33.61, indicating a neutral trend. The MACD of 0.19 indicates Positive momentum. The RSI at 46.81 is Neutral, neither overbought nor oversold. The STOCH value of 19.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AMID.

AMID Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$108.56M0.52%
$421.93M0.20%
$287.77M0.55%
$282.53M0.18%
$144.80M0.60%
$110.44M0.68%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMID
Argent Mid Cap ETF
34.52
-1.27
-3.55%
AVMV
Avantis U.S. Mid Cap Value ETF
TMVE
Thrivent Mid Cap Value ETF
AVMC
Avantis U.S. Mid Cap Equity ETF
FRTY
Alger Mid Cap 40 ETF
AFMC
First Trust Active Factor Mid Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement